About
BÂRRX Medical is a medical device company focused on developing endoscopic treatment solutions for Barrett's esophagus and other chronic gastroenterological diseases. Co-founded by Stellartech Research Corp. and two physician partners, the company addresses a critical patient need with a minimally invasive outpatient procedure that ablates diseased esophageal tissue. The flagship product features a radiofrequency (RF) energy delivery system that effectively treats Barrett’s esophagus by uniformly ablating the mucous lining of the esophagus. This innovative technology enhances patient convenience and reduces healthcare costs compared to more invasive surgical options. BÂRRX Medical primarily serves gastroenterologists, healthcare providers specializing in endoscopic procedures, and hospitals and outpatient clinics managing patients with Barrett’s esophagus and related conditions. In 2011, BÂRRX Medical was acquired by Covidien for $325 million, highlighting the significant value and clinical impact of its technology in the medical device market.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2001
-
Annual Revenue $10000000
-
Total Funding $42800000
Location
710 Medtronic Parkway Northeast, Minneapolis, Minnesota, United States, 55432
